A better quality of life for our patients

Our research includes diverse areas of study,

  • starting from exploring the underlying causes of the arrhythmia,
  • the individual’s genetic background, the circulating biomarkers and interactions that occur in every patient;
  • towards more complex and clinical approaches trying to integrate mechanistic informatics to a personalized treatment for people at risk or with atrial fibrillation.

We increasingly focus on the interaction between atrial fibrillation and heart failure, especially heart failure with a preserved ejection fraction.

Our aim is to unravel all that is yet to be known about atrial fibrillation, in order to attain a better understanding of the condition; to be able to act by preventing cardiovascular outcomes or consequences derived from atrial fibrillation (e.g. stroke and heart failure) and to achieve a better quality of life for our patients.